Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 8152526, 8 pages
https://doi.org/10.1155/2017/8152526
Research Article

Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells

1Department of Neurosurgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
2Department of Neurosurgery, Yancheng City No. 1 People’s Hospital, The Fourth Affiliated Hospital of Nantong Medical College, Yancheng, China
3Department of Endocrinology, Yancheng Third Hospital, The Affiliated Hospital of Southeast University Medical College, Yancheng, China

Correspondence should be addressed to Ning Liu; moc.621@3580gninuil

Received 15 February 2017; Accepted 28 June 2017; Published 13 August 2017

Academic Editor: Yoshiyuki Kimura

Copyright © 2017 Feng Jia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Feng Jia, Shu Ruan, Ning Liu, and Linshan Fu, “Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 8152526, 8 pages, 2017. https://doi.org/10.1155/2017/8152526.